These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28840058)

  • 1. P2X
    Pasqualetti G; Seghieri M; Santini E; Rossi C; Vitolo E; Giannini L; Malatesta MG; Calsolaro V; Monzani F; Solini A
    Aging Dis; 2017 Jul; 8(4):434-441. PubMed ID: 28840058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-type natriuretic peptide may predict prognosis in older adults admitted with a diagnosis other than heart failure.
    Di Marca S; Rando A; Cataudella E; Pulvirenti A; Alaimo S; Terranova V; Corriere T; Pisano M; Di Quattro R; Ronsisvalle ML; Giraffa CM; Giordano M; Stancanelli B; Malatino L
    Nutr Metab Cardiovasc Dis; 2018 Jun; 28(6):636-642. PubMed ID: 29625779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of short-term follow-up BNP in hospitalized patients with heart failure.
    Khanam SS; Son JW; Lee JW; Youn YJ; Yoon J; Lee SH; Kim JY; Ahn SG; Ahn MS; Yoo BS
    BMC Cardiovasc Disord; 2017 Aug; 17(1):215. PubMed ID: 28774268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poor prognosis of heart failure patients with in-hospital worsening renal function and elevated BNP at discharge.
    Okabe T; Yakushiji T; Kido T; Kimura T; Asukai Y; Shimazu S; Saito J; Oyama Y; Igawa W; Ono M; Ebara S; Yamashita K; Yamamoto MH; Amemiya K; Isomura N; Ochiai M
    ESC Heart Fail; 2020 Oct; 7(5):2912-2921. PubMed ID: 32643875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and cost-effectiveness of serum B-type natriuretic peptide testing and monitoring in patients with heart failure in primary and secondary care: an evidence synthesis, cohort study and cost-effectiveness model.
    Pufulete M; Maishman R; Dabner L; Mohiuddin S; Hollingworth W; Rogers CA; Higgins J; Dayer M; Macleod J; Purdy S; McDonagh T; Nightingale A; Williams R; Reeves BC
    Health Technol Assess; 2017 Aug; 21(40):1-150. PubMed ID: 28774374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and prognostic value of brain natriuretic peptide (BNP) concentrations in very elderly heart disease patients: specific geriatric cut-off and impacts of age, gender, renal dysfunction, and nutritional status.
    Blondé-Cynober F; Morineau G; Estrugo B; Fillie E; Aussel C; Vincent JP
    Arch Gerontol Geriatr; 2011; 52(1):106-10. PubMed ID: 20226544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How often we need to measure brain natriuretic peptide (BNP) blood levels in patients admitted to the hospital for acute severe heart failure? Role of serial measurements to improve short-term prognostic stratification.
    Faggiano P; Valle R; Aspromonte N; D'Aloia A; Di Tano G; Barro S; Giovinazzo P; Milani L; Lorusso R; Dei Cas L
    Int J Cardiol; 2010 Apr; 140(1):88-94. PubMed ID: 19321212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [BNP-guided therapy optimizes the timing of discharge and the medium term risk stratification in patients admitted for congestive heart failure].
    Valle R; Aspromonte N; Carbonieri E; De Michele G; Di Tano G; Giovinazzo P; Cioè R; Di Giacomo T; Milani L; Noventa F; Chiatto M
    Monaldi Arch Chest Dis; 2007 Sep; 68(3):154-64. PubMed ID: 18361212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid assay brain natriuretic peptide and troponin I in patients hospitalized with decompensated heart failure (from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness Trial).
    Shah MR; Hasselblad V; Tasissa G; Christenson RH; Binanay C; O'Connor CM; Ohman EM; Stevenson LW; Califf RM
    Am J Cardiol; 2007 Nov; 100(9):1427-33. PubMed ID: 17950802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low prevalence of B-type natriuretic peptide levels < 100 pg/mL in patients with heart failure at hospital discharge.
    Hogenhuis J; Voors AA; Jaarsma T; Hillege HL; Hoes AW; van Veldhuisen DJ
    Am Heart J; 2006 May; 151(5):1012.e1-5. PubMed ID: 16644323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of mortality with Pro-BNP and precipitating factors of acute heart failure in patients presenting to a medical emergency of tertiary care hospital: an observational study from north India.
    Bhatia MS; Sharda SC; Attri R; Pannu AK; Dahiya N
    Eur Rev Med Pharmacol Sci; 2022 Sep; 26(18):6459-6468. PubMed ID: 36196696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utilization and prognostic impact of B-type Natriuretic Peptide in hospitalized acute decompensated heart failure in an Asian population.
    Chen LJ; Hung CL; Yeh HI; Jeng MJ; Su CH; Wu TY; Shih SC; Tsai CH
    BMC Cardiovasc Disord; 2016 Sep; 16(1):178. PubMed ID: 27613439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.
    Nishii M; Inomata T; Takehana H; Naruke T; Yanagisawa T; Moriguchi M; Takeda S; Izumi T
    J Am Coll Cardiol; 2008 Jun; 51(24):2329-35. PubMed ID: 18549918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of B-Type Natriuretic Peptide Level on Long-Term Outcome in Patients With End-Stage Heart Failure.
    Huang B; Shen J; Li L; Huang Y; Luo S
    Am J Cardiol; 2016 Aug; 118(3):383-8. PubMed ID: 27269584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
    Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
    Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Admission, discharge, or change in B-type natriuretic peptide and long-term outcomes: data from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) linked to Medicare claims.
    Kociol RD; Horton JR; Fonarow GC; Reyes EM; Shaw LK; O'Connor CM; Felker GM; Hernandez AF
    Circ Heart Fail; 2011 Sep; 4(5):628-36. PubMed ID: 21743005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study.
    Daniels LB; Clopton P; Bhalla V; Krishnaswamy P; Nowak RM; McCord J; Hollander JE; Duc P; Omland T; Storrow AB; Abraham WT; Wu AH; Steg PG; Westheim A; Knudsen CW; Perez A; Kazanegra R; Herrmann HC; McCullough PA; Maisel AS
    Am Heart J; 2006 May; 151(5):999-1005. PubMed ID: 16644321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma level of N-terminal pro brain natriuretic peptide (NT-proBNP) in elderly population in Poland--the PolSenior Study.
    Nadrowski P; Chudek J; Grodzicki T; Mossakowska M; Skrzypek M; Wiecek A; Zdrojewski T; Kozakiewicz K
    Exp Gerontol; 2013 Sep; 48(9):852-7. PubMed ID: 23770107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of APOE ε4 Allele and Incident Stroke on Cognitive Decline and Mortality.
    Rajan KB; Aggarwal NT; Schneider JA; Wilson RS; Everson-Rose SA; Evans DA
    Alzheimer Dis Assoc Disord; 2016; 30(4):318-323. PubMed ID: 27849638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.